Botanical draft guidance
This article was originally published in The Tan Sheet
Executive Summary
FDA is reopening comment period for draft guidance for industry entitled "Botanical Drug Products" until March 15. The guidance, originally published in Aug. 11 Federal Register, provides industry with FDA's interpretation of what is needed to get botanicals approved as OTC drugs (1"The Tan Sheet" Aug. 14, p. 6)